|
시장보고서
상품코드
1915445
지루성 각화증 치료 시장(2025-2029년)Global Seborrheic Keratosis Treatment Market 2025-2029 |
||||||
세계의 지루성 각화증 치료 시장은 2024-2029년 7억 8,110만 달러 증가하고, 예측 기간 중 연평균 복합 성장률(CAGR)은 6.1%를 나타낼 것으로 예측됩니다. 본 보고서에서는 세계의 지루성 각화증 치료 시장에 관한 종합적 분석, 시장 규모와 예측, 동향, 성장요인, 과제 및 약 25개사 벤더 분석 등의 정보를 제공합니다.
본 보고서는 현재 시장 상황, 최신 동향 및 성장요인, 시장 환경 전반에 대한 최신 분석을 제공합니다. 이 시장은 미적 감각에 대한 선호도 증가, 지루성 각화증의 높은 유병률, 고령 인구의 급증에 의해 주도되고 있습니다.
이번 조사는 업계 주요 관계자들의 정보를 포함한 1차 정보와 2차 정보의 객관적인 조합을 통해 이루어졌습니다. 이 보고서에는 주요 기업 분석과 함께 종합적인 시장 규모 데이터, 지역별 분석과 함께 부문 및 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 수록되어 있습니다.
| 시장 범위 | |
|---|---|
| 기준 연도 | 2025년 |
| 대상 기간 | 2029년 |
| 예측 기간 | 2025년-2029년 |
| 성장 모멘텀 | 가속 |
| 전년대비 | 5.7% |
| CAGR | 6.1% |
| 증가액 | 7억 8,110만 달러 |
이 보고서는 향후 몇 년 동안 세계 지루성 각화증 치료 시장 성장의 주요 촉진요인 중 하나로 냉동 요법의 기술적 진보를 꼽고 있습니다. 또한, 비침습적 치료법의 출현과 레이저 치료의 활용이 시장에서 상당한 수요를 창출할 것으로 예측됩니다.
목차
제1장 주요 요약
제2장 Technavio 분석
- 가격, 수명주기, 고객 구입 바스켓, 채택 비율, 구입 기준 분석
- 인풋의 중요성과 차별화 요인
- 혼란 요인
- 성장 촉진요인과 과제의 영향
제3장 시장 구도
- 시장 생태계
- 시장 특징
- 밸류체인 분석
제4장 시장 규모
- 시장의 정의
- 시장 부문 분석
- 시장 규모(2024년)
- 시장 전망(2024-2029년)
제5장 시장 규모 실적
- 세계의 지루성 각화증 치료 시장(2019-2023년)
- 용도별 분석(2019-2023년)
- 기술별 분석(2019-2023년)
- 최종사용자별 분석(2019-2023년)
- 지역별 분석(2019-2023년)
- 국가별 분석(2019-2023년)
제6장 정성 분석
- AI의 영향 : 세계의 지루성 각화증 치료 시장
제7장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁 위협
- 시장 현황
제8장 시장 세분화 : 용도별
- 비교 : 용도별
- 냉동요법
- 전기소작
- 기타
- 시장 기회 : 용도별
제9장 시장 세분화 : 기술별
- 비교 : 기술별
- CO2 레이저
- 에르븀 레이저
- 분할 레이저
- 과산화수소 기반 국소제
- 시장 기회 : 기술별
제10장 시장 세분화 : 최종사용자별
- 비교 : 최종사용자별
- 피부과 클리닉
- 병원
- 외래수술센터(ASC)
- 재택 헬스케어
- 시장 기회 : 최종사용자별
제11장 고객 상황
제12장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 네덜란드
- 아시아
- 중국
- 인도
- 일본
- 한국
- 인도네시아
- 태국
- 세계 기타 지역
- 브라질
- 사우디아라비아
- 아랍에미리트(UAE)
- 튀르키예
- 아르헨티나
- 콜롬비아
- 남아프리카공화국
- 이스라엘
- 시장 기회 : 지역별
제13장 촉진요인·과제·기회
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회
제14장 경쟁 구도
- 개요
- 경쟁 구도
- 파괴적 혁신 상황
- 업계 리스크
제15장 경쟁 분석
- 기업 개요
- 기업 순위 지표
- 기업의 시장 포지셔닝
- ACLARIS THERAPEUTICS INC.
- BioLineRx Ltd.
- Brymill Cryogenic Systems
- Cortex Technology
- Cryo Innovations
- CryoConcepts LP
- Cryoswiss GmbH
- Cutera Inc.
- Erbe Elektromedizin GmbH
- H and O Equipments
- Lumenis Be Ltd.
- Mectronic Medicale Srl
- METRUM CRYOFLEX SP ZOO SPK
- Quanta System S.p.A.
- Special Medical Technology s.r.o
제16장 부록
LSH 26.02.04The global seborrheic keratosis treatment market is forecasted to grow by USD 781.1 mn during 2024-2029, accelerating at a CAGR of 6.1% during the forecast period. The report on the global seborrheic keratosis treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing preference for aesthetic quotient, high prevalence of seborrheic keratosis, surge in geriatric population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 5.7% |
| CAGR | 6.1% |
| Incremental Value | $781.1 mn |
Technavio's global seborrheic keratosis treatment market is segmented as below:
By Application
- Cryotherapy
- Electrocautery
- Others
By Technology
- CO2 laser
- Erbium laser
- Fractional laser
- Hydrogen peroxide-based topicals
By End-User
- Dermatology clinics
- Hospitals
- Ambulatory surgical centers
- Home healthcare
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the technological advances in cryotherapy as one of the prime reasons driving the global seborrheic keratosis treatment market growth during the next few years. Also, emergence of non-invasive treatments and use of laser therapy will lead to sizable demand in the market.
The report on the global seborrheic keratosis treatment market covers the following areas:
- Global seborrheic keratosis treatment market sizing
- Global seborrheic keratosis treatment market forecast
- Global seborrheic keratosis treatment market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global seborrheic keratosis treatment market vendors that include ACLARIS THERAPEUTICS INC., BioLineRx Ltd., Brymill Cryogenic Systems, Cortex Technology, Cryo Innovations, CryoConcepts LP, Cryoswiss GmbH, Cutera Inc., EpiPharm AG, Erbe Elektromedizin GmbH, H and O Equipments, Lumenis Be Ltd., Mectronic Medicale Srl, METRUM CRYOFLEX SP ZOO SPK, Quanta System S.p.A., Special Medical Technology s.r.o, Symmetry Surgical Inc.. Also, the global seborrheic keratosis treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
5 Historic Market Size
- 5.1 Global Seborrheic Keratosis Treatment Market 2019 - 2023
- Historic Market Size - Data Table on Global Seborrheic Keratosis Treatment Market 2019 - 2023 ($ million)
- 5.2 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
- 5.3 Technology segment analysis 2019 - 2023
- Historic Market Size - Technology Segment 2019 - 2023 ($ million)
- 5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Seborrheic Keratosis Treatment Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
8 Market Segmentation by Application
- 8.1 Market segments
- 8.2 Comparison by Application
- 8.3 Cryotherapy - Market size and forecast 2024-2029
- 8.4 Electrocautery - Market size and forecast 2024-2029
- 8.5 Others - Market size and forecast 2024-2029
- 8.6 Market opportunity by Application
- Market opportunity by Application ($ million)
9 Market Segmentation by Technology
- 9.1 Market segments
- 9.2 Comparison by Technology
- 9.3 CO2 laser - Market size and forecast 2024-2029
- 9.4 Erbium laser - Market size and forecast 2024-2029
- 9.5 Fractional laser - Market size and forecast 2024-2029
- 9.6 Hydrogen peroxide-based topicals - Market size and forecast 2024-2029
- 9.7 Market opportunity by Technology
- Market opportunity by Technology ($ million)
10 Market Segmentation by End-user
- 10.1 Market segments
- 10.2 Comparison by End-user
- 10.3 Dermatology clinics - Market size and forecast 2024-2029
- 10.4 Hospitals - Market size and forecast 2024-2029
- 10.5 Ambulatory surgical centers - Market size and forecast 2024-2029
- 10.6 Home healthcare - Market size and forecast 2024-2029
- 10.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2024-2029
- 12.3.1 US - Market size and forecast 2024-2029
- 12.3.2 Canada - Market size and forecast 2024-2029
- 12.3.3 Mexico - Market size and forecast 2024-2029
- 12.4 Europe - Market size and forecast 2024-2029
- 12.4.1 Germany - Market size and forecast 2024-2029
- 12.4.2 UK - Market size and forecast 2024-2029
- 12.4.3 France - Market size and forecast 2024-2029
- 12.4.4 Italy - Market size and forecast 2024-2029
- 12.4.5 Spain - Market size and forecast 2024-2029
- 12.4.6 The Netherlands - Market size and forecast 2024-2029
- 12.5 Asia - Market size and forecast 2024-2029
- 12.5.1 China - Market size and forecast 2024-2029
- 12.5.2 India - Market size and forecast 2024-2029
- 12.5.3 Japan - Market size and forecast 2024-2029
- 12.5.4 South Korea - Market size and forecast 2024-2029
- 12.5.5 Indonesia - Market size and forecast 2024-2029
- 12.5.6 Thailand - Market size and forecast 2024-2029
- 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- 12.6.1 Brazil - Market size and forecast 2024-2029
- 12.6.2 Saudi Arabia - Market size and forecast 2024-2029
- 12.6.3 UAE - Market size and forecast 2024-2029
- 12.6.4 Turkey - Market size and forecast 2024-2029
- 12.6.5 Argentina - Market size and forecast 2024-2029
- 12.6.6 Colombia - Market size and forecast 2024-2029
- 12.6.7 South Africa - Market size and forecast 2024-2029
- 12.6.8 Israel - Market size and forecast 2024-2029
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Growing preference for aesthetic quotient
- High prevalence of seborrheic keratosis
- Surge in geriatric population
- 13.2 Market challenges
- Lack of approved drug therapies
- High cost of treatment
- Challenges associated with misdiagnosis
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 13.4 Market opportunities
- Technological advances in cryotherapy
- Emergence of non-invasive treatments
- Use of laser therapy
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 ACLARIS THERAPEUTICS INC.
- ACLARIS THERAPEUTICS INC. - Overview
- ACLARIS THERAPEUTICS INC. - Product / Service
- ACLARIS THERAPEUTICS INC. - Key offerings
- SWOT
- 15.5 BioLineRx Ltd.
- BioLineRx Ltd. - Overview
- BioLineRx Ltd. - Product / Service
- BioLineRx Ltd. - Key offerings
- SWOT
- 15.6 Brymill Cryogenic Systems
- Brymill Cryogenic Systems - Overview
- Brymill Cryogenic Systems - Product / Service
- Brymill Cryogenic Systems - Key offerings
- SWOT
- 15.7 Cortex Technology
- Cortex Technology - Overview
- Cortex Technology - Product / Service
- Cortex Technology - Key offerings
- SWOT
- 15.8 Cryo Innovations
- Cryo Innovations - Overview
- Cryo Innovations - Product / Service
- Cryo Innovations - Key offerings
- SWOT
- 15.9 CryoConcepts LP
- CryoConcepts LP - Overview
- CryoConcepts LP - Product / Service
- CryoConcepts LP - Key offerings
- SWOT
- 15.10 Cryoswiss GmbH
- Cryoswiss GmbH - Overview
- Cryoswiss GmbH - Product / Service
- Cryoswiss GmbH - Key offerings
- SWOT
- 15.11 Cutera Inc.
- Cutera Inc. - Overview
- Cutera Inc. - Product / Service
- Cutera Inc. - Key news
- Cutera Inc. - Key offerings
- SWOT
- 15.12 Erbe Elektromedizin GmbH
- Erbe Elektromedizin GmbH - Overview
- Erbe Elektromedizin GmbH - Product / Service
- Erbe Elektromedizin GmbH - Key offerings
- SWOT
- 15.13 H and O Equipments
- H and O Equipments - Overview
- H and O Equipments - Product / Service
- H and O Equipments - Key offerings
- SWOT
- 15.14 Lumenis Be Ltd.
- Lumenis Be Ltd. - Overview
- Lumenis Be Ltd. - Product / Service
- Lumenis Be Ltd. - Key offerings
- SWOT
- 15.15 Mectronic Medicale Srl
- Mectronic Medicale Srl - Overview
- Mectronic Medicale Srl - Product / Service
- Mectronic Medicale Srl - Key offerings
- SWOT
- 15.16 METRUM CRYOFLEX SP ZOO SPK
- METRUM CRYOFLEX SP ZOO SPK - Overview
- METRUM CRYOFLEX SP ZOO SPK - Product / Service
- METRUM CRYOFLEX SP ZOO SPK - Key offerings
- SWOT
- 15.17 Quanta System S.p.A.
- Quanta System S.p.A. - Overview
- Quanta System S.p.A. - Product / Service
- Quanta System S.p.A. - Key offerings
- SWOT
- 15.18 Special Medical Technology s.r.o
- Special Medical Technology s.r.o - Overview
- Special Medical Technology s.r.o - Product / Service
- Special Medical Technology s.r.o - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
